@article{PAR00008935,
  title = {{U}pdate on {W}orld {H}ealth {O}rganization {HIV} drug resistance prevention and assessment strategy : 2004-2011},
  author = {{J}ordan, {M}. {R}. and {B}ennett, {D}. {E}. and {W}ainberg, {M}. {A}. and {H}avlir, {D}. and {H}ammer, {S}. and {Y}ang, {C}. and {M}orris, {L}. and {P}eeters, {M}artine and {W}ensing, {A}. {M}. and {P}arkin, {N}. and {N}achega, {J}. {B}. and {P}hillips, {A}. and {D}e {L}uca, {A}. and {G}eng, {E}. and {C}almy, {A}. and {R}aizes, {E}. and {S}andstrom, {P}. and {A}rchibald, {C}. {P}. and {P}erriens, {J}. and {M}c{C}lure, {C}. {M}. and {H}ong, {S}. {Y}. and {M}c{M}ahon, {J}. {H}. and {D}edes, {N}. and {S}utherland, {D}. and {B}ertagnolio, {S}.},
  editor = {},
  language = {{ENG}},
  abstract = {{T}he {HIV} drug resistance ({HIVDR}) prevention and assessment strategy, developed by the {W}orld {H}ealth {O}rganization ({WHO}) in partnership with {HIVR}es{N}et, includes monitoring of {HIVDR} early warning indicators, surveys to assess acquired and transmitted {HIVDR}, and development of an accredited {HIVDR} genotyping laboratory network to support survey implementation in resource-limited settings. {A}s of {J}une 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. {A}s access to antiretrovirals expands under the {WHO}/{J}oint {U}nited {N}ations {P}rogramme on {HIV}/{AIDS} {T}reatment 2.0 initiative, it is essential to strengthen {HIVDR} surveillance efforts in the face of increasing concern about {HIVDR} emergence and transmission.},
  keywords = {},
  booktitle = {},
  journal = {{C}linical {I}nfectious {D}iseases},
  volume = {54},
  numero = {4},
  pages = {{S}245--{S}249},
  ISSN = {1058-4838},
  year = {2012},
  DOI = {10.1093/cid/cis206},
  URL = {https://www.documentation.ird.fr/hor/{PAR}00008935},
}